Drug companies gave at least $116 million to patient advocacy groups in 2015, according to a database launched Friday by Kaiser Health News. “Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration,” KHN writes. “But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups. The Pre$cription for Power database will be available for downloading in May. The database currently covers 2015 and will be updated as additional data become available.”

Related News Articles

Headline
The House Budget Committee today held a hearing on the Congressional Budget Office’s recent report on key design components and considerations for policymakers…
Headline
The Department of Health and Human Services aims to release proposed rules amending the physician self-referral (Stark law) regulations and safe-harbors under…
Headline
The Department of Health and Human Services Office for Civil Rights today published in the Federal Register its final rule concerning federal health care-…
Blog
Last week, researchers at RAND released a study that made broad claims about the prices that private insurers pay hospitals. The RAND authors relied on…
Headline
Sens. Bill Cassidy, R-La., Michael Bennet, D-Colo., Todd Young, R-Ind., Maggie Hassan, D-N.H., Lisa Murkowski, R-Alaska, and Tom Carper, D-Del., today…
Blog
Earlier this week, Politico published cherry-picked metrics from the recently released Moody’s Preliminary Medians for not-for-profit and public hospitals.